The authors note that “components of the sarcosine pathway [which include the ERG gene fusion product and the androgen receptor] may have potential as biomarkers of prostate cancer progression ...

Background: Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case–control evaluation of the predictive value of ...